
Engine Biosciences uses machine learning and genomics to identify and validate new therapeutic targets and reprogram cell states. The company combines network biomedicine with high-throughput wet-lab experimentation and artificial intelligence algorithms to map complex biological networks and predict interventions, including cellular reprogramming strategies. Its proprietary, patented platform integrates genomics data, ML models, and experimental validation to accelerate drug discovery workflows. Engine works with internal R&D programs and external pharmaceutical and biotech partners to advance candidate therapies across multiple disease indications.

Engine Biosciences uses machine learning and genomics to identify and validate new therapeutic targets and reprogram cell states. The company combines network biomedicine with high-throughput wet-lab experimentation and artificial intelligence algorithms to map complex biological networks and predict interventions, including cellular reprogramming strategies. Its proprietary, patented platform integrates genomics data, ML models, and experimental validation to accelerate drug discovery workflows. Engine works with internal R&D programs and external pharmaceutical and biotech partners to advance candidate therapies across multiple disease indications.